3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1. 2004

Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
Department of Medicinal Chemistry, The Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK. robert.carling@merck.com

Studies with our screening lead 5 and the literature compound 6 led to the identification of 6-benzyloxy-3-(4-methoxy)phenyl-1,2,4-triazolo[3,4-a]phthalazine 8 as a ligand with binding selectivity for the gamma-aminobutyric acid-A (GABA-A) alpha 3- and alpha 5-containing receptor subtypes over the GABA-A alpha 1 subtype (K(i): alpha 2 = 850 nM, alpha 3 = 170 nM, alpha 5 = 72 nM, alpha 1 = 1400 nM). Early optimization studies identified the close analogue 10 (K(i): alpha 2 = 16 nM, alpha 3 = 41 nM, alpha 5 = 38 nM, alpha 1 = 280 nM) as a suitable lead for further study. High-affinity ligands were identified by replacing the 6-benzyloxy group of compound 10 with 2-pyridylmethoxy (compound 29), but binding selectivity was not enhanced (K(i): alpha 2 = 1.7 nM, alpha 3 = 0.71 nM, alpha 5 = 0.33 nM, alpha 1 = 2.7 nM). Furthermore, on evaluation in xenopus oocytes,(22) 29 was discovered to be a weak to moderate inverse agonist at all four receptor subtypes (alpha 1, -7%; alpha 2, -5%; alpha 3, -16%; alpha 5, -5%). Replacement of the 3-phenyl group of 29 with alternatives led to reduced affinity, and smaller 3-substituents led to reduced efficacy. Methyl substitution of the benzo-fused ring of 29 at the 7-, 8-, and 10-positions resulted in increased efficacy although selectivity was abolished. Increased efficacy and retention of selectivity for alpha 3 over alpha 1 was achieved with the 7,8,9,10-tetrahydro-(7,10-ethano)-phthalazine 62. Compound 62 is currently one of the most binding selective GABA-A alpha 3-benzodiazepine-site partial agonists known, and although its selectivity is limited, its good pharmacokinetic profile in the rat (33% oral bioavailability after a 3 mg/kg dose, reaching a peak plasma concentration of 179 ng/mL; half-life of 1 h) made it a useful pharmacological tool to explore the effect of a GABA-A alpha 2/alpha 3 agonist in vivo.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
June 1988, Journal of medicinal chemistry,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
January 1989, Farmaco (Societa chimica italiana : 1989),
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
November 1988, Il Farmaco; edizione scientifica,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
November 2005, Acta crystallographica. Section C, Crystal structure communications,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
January 2010, Acta crystallographica. Section E, Structure reports online,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
February 1988, Il Farmaco; edizione scientifica,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
March 2009, Chemical biology & drug design,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
April 2010, Acta crystallographica. Section E, Structure reports online,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
May 1999, The Journal of biological chemistry,
Robert W Carling, and Kevin W Moore, and Leslie J Street, and Deborah Wild, and Catherine Isted, and Paul D Leeson, and Steven Thomas, and Desmond O'Connor, and Ruth M McKernan, and Katherine Quirk, and Susan M Cook, and John R Atack, and Keith A Wafford, and Sally A Thompson, and Gerard R Dawson, and Pushpinder Ferris, and José L Castro
November 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Copied contents to your clipboard!